NEW YORK (GenomeWeb) – Genetic variants in the PCSK9 gene have the same effect on cardiovascular disease and diabetes risk as variants within the HMGCR gene, which encodes the target of lipid-lowering statins.

According to an international team of researchers, this suggests that therapies targeting PCSK9 should have similar effects as statins on cardiovascular events, but with the same potential risk of developing diabetes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.